Trial intelligence / Profile preview

Extended-release niacin effect on myocardial blood flow reserve in statin-treated coronary artery disease

2005-004218-34Phase 3Terminated

Sponsor
Department of Cardiology, University Hospital Aachen
Start
Feb 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of niacin in coronary arteriosclerosis and lipid disorder, sponsored by Department of Cardiology, University Hospital Aachen. Primary endpoint: Myocardial blood flow and flow reserve change. Started Feb 2006; status: terminated.

02

Drugs

niacin
03

Conditions

coronary arteriosclerosislipid disorder

Beyond the preview

Go deeper on 2005-004218-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004218-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call